Actively Recruiting

Phase Not Applicable
Age: 18Years - 50Years
All Genders
Healthy Volunteers
NCT07019519

POTS-FLOW: Interplay Between Gut Hormones and Autonomic Postprandial Blood Flow Regulation in Patients With POTS

Led by University of Copenhagen · Updated on 2025-06-13

30

Participants Needed

1

Research Sites

80 weeks

Total Duration

On this page

Sponsors

U

University of Copenhagen

Lead Sponsor

R

Rigshospitalet, Denmark

Collaborating Sponsor

AI-Summary

What this Trial Is About

This study will describe the interplay between the gut hormones GIP and CCK and their regulation of blood flow to the large vessels in patients with Postural Orthostatic Tachycardia Syndrome (POTS) and GIP, CCK and GLP-1 in healthy. This is addressed by hormone infusions during MR-scans of the abdomen and intake of oral glucose.

CONDITIONS

Official Title

POTS-FLOW: Interplay Between Gut Hormones and Autonomic Postprandial Blood Flow Regulation in Patients With POTS

Who Can Participate

Age: 18Years - 50Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 to 50 years
  • Waist circumference less than 180 cm
  • For POTS patients: diagnosed by tilt test or active stand test with reproducible orthostatic intolerance and heart rate increase (over 30 bpm for age above 19, over 40 bpm for age 18-19)
  • POTS symptoms or orthostatic intolerance for POTS group
  • For healthy participants: matched by age, sex, and BMI to POTS patients
Not Eligible

You will not qualify if you...

  • Chronic illness
  • Metallic implants
  • More than 10 alcoholic drinks per week or substance abuse
  • Other types of sinus tachycardia or heart disease (for POTS group)
  • Liver enzymes elevated to twice above normal
  • Reduced kidney function (eGFR less than 90) or elevated creatine kinase
  • Thyroid disease or abnormal TSH levels
  • Uncontrolled low or high blood pressure
  • Orthostatic hypotension (for healthy group)
  • Blood vessels that cannot be visualized on MR scans
  • Any disease or medications that cannot be paused for 36 hours and might affect health during the study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Rigshospitalet

Copenhagen, Denmark, 2100

Actively Recruiting

Loading map...

Research Team

S

Sophie W Nielsen, MD

CONTACT

L

Lærke S Gasbjerg, MD, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

BASIC_SCIENCE

Number of Arms

4

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here